DOJ Introduces Novel Theories of Liability and Requires Unprecedented Controls in Speaker Program Settlement
In August 2020, Novartis Pharmaceuticals Corporation entered into a $678 million civil settlement agreement with the DOJ to resolve allegations that, as an inducement to prescribe Novartis' drugs, the company paid health care practitioners who served as speakers for or simply attended Novartis events.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year